Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “mRNA Vaccination”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06891417
What this trial is testing

Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years

Who this might be right for
Chlamydia Trachomatis Immunization
Sanofi 1,560
Early research (Phase 1)Study completedNCT05477186
What this trial is testing

Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old

Who this might be right for
COVID-19SARS-CoV-2
GlaxoSmithKline 185
Not applicableStudy completedNCT04928456
What this trial is testing

Augmentation of Immune Response to COVID-19 mRNA Vaccination Through OMT With Lymphatic Pumps

Who this might be right for
Covid19
Western University of Health Sciences 92
Not applicableUnknownNCT04900467
What this trial is testing

Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine

Who this might be right for
Adult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second Dose
Assistance Publique - Hôpitaux de Paris 418
Large-scale testing (Phase 3)UnknownNCT05636319
What this trial is testing

Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Vaccine

Who this might be right for
COVID-19
Suzhou Abogen Biosciences Co., Ltd. 14,168
Early research (Phase 1)Study completedNCT05743335
What this trial is testing

Assess the Safety and Immunogenicity of JCXH-221, an MRNA-based Broadly Protective COVID-19 Vaccine

Who this might be right for
COVID-19Infectious Disease
Immorna Biotherapeutics, Inc. 73
Post-approval studies (Phase 4)Study completedNCT05057182
What this trial is testing

Third Dose of mRNA Vaccination to Boost COVID-19 Immunity (mBoost Study)

Who this might be right for
COVID 19 Vaccine
The University of Hong Kong 300
Large-scale testing (Phase 3)Ended earlyNCT05228730
What this trial is testing

Evaluation of Full Versus Fractional Doses of COVID-19 Vaccines Given as a Booster in Adults in Australia - Mongolia, Indonesia, Australia Coronavirus (MIACoV).

Who this might be right for
COVID-19
Murdoch Childrens Research Institute 13
Large-scale testing (Phase 3)WithdrawnNCT05387317
What this trial is testing

Evaluation of COVID-19 Vaccines Given as a Booster in Healthy Adults in Indonesia (MIACoV Indonesia)

Who this might be right for
COVID-19
Murdoch Childrens Research Institute
Testing effectiveness (Phase 2)Study completedNCT00204607
What this trial is testing

Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients

Who this might be right for
Malignant Melanoma
University Hospital Tuebingen 20
Not applicableStudy completedNCT05440318
What this trial is testing

Use of Wearable Digital Sensors After mRNA Vaccination in Adults

Who this might be right for
Healthy Participants
ModernaTX, Inc. 62
Early research (Phase 1)Study completedNCT01995708
What this trial is testing

CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT06361875
What this trial is testing

Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and Above

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 908
Not applicableStudy completedNCT05104385
What this trial is testing

Hacettepe University COVID-19 Vaccinated's Health Cohort- Students of Health Sciences

Who this might be right for
COVID-19 PandemicSARS-CoV2 InfectionImmunization; Infection+1 more
Hacettepe University 1,223
Not applicableStudy completedNCT05060354
What this trial is testing

COVID-19 Vaccine Response in Treated MS Patients

Who this might be right for
Multiple SclerosisHealthy
Brigham and Women's Hospital 159
Not applicableStudy completedNCT05020145
What this trial is testing

COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States

Who this might be right for
ImmunocompromisedImmunosuppressedCovid-19+3 more
Pfizer 1,277,747
Large-scale testing (Phase 3)Study completedNCT05364242
What this trial is testing

VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection

Who this might be right for
SARS-CoV-2 Infection
Valneva Austria GmbH 178
Not applicableStudy completedNCT05270967
What this trial is testing

FDG (Fluorodeoxyglucose) Findings After COVID-19 Vaccination

Who this might be right for
Vaccine ReactionOncology
Kocaeli University 129
Large-scale testing (Phase 3)Study completedNCT05265065
What this trial is testing

Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia.

Who this might be right for
COVID-19
Murdoch Childrens Research Institute 601
Early research (Phase 1)Active Not RecruitingNCT06564194
What this trial is testing

Evaluate JCXH-108, an mRNA-based Vaccine Against RSV

Who this might be right for
Respiratory Syncytial Virus (RSV)Infectious Disease
Immorna Biotherapeutics, Inc. 75
Next Page